By Myrna Monk
DOWNLOAD REPORT
Summary: Maintaining the blind in randomized clinical trials is especially challenging for injectable drug products, where even minor differences in appearance, viscosity, or injection experience can reveal treatment assignment. Designing a matching parenteral placebo requires replicating the active product’s sensory and physical attributes—such as clarity, color, osmolality, pH, and injection feel—without including the active ingredient, while ensuring sterility and stability.
This report outlines when and why a custom placebo is needed, referencing ICH E10 guidance and the importance of integrating clinical study design, user handling, and the administration setting into placebo selection. Sensory discrimination testing can determine whether differences between active and potential placebo options are detectable and whether custom manufacturing is required.
Placebo design considerations differ across IV vials, subcutaneous injections, and pre-filled syringe or combination products. Formulation strategies typically mirror the excipient system of the investigational drug using high-purity, parenteral-grade components. Ultimately, a well-designed placebo supports patient blinding, prevents bias, and helps maintain the scientific integrity of clinical trial outcomes.
Read Part II >